PL3430031T3 - Peptydy o aktywności przeciwnowotworowej - Google Patents
Peptydy o aktywności przeciwnowotworowejInfo
- Publication number
- PL3430031T3 PL3430031T3 PL17710545T PL17710545T PL3430031T3 PL 3430031 T3 PL3430031 T3 PL 3430031T3 PL 17710545 T PL17710545 T PL 17710545T PL 17710545 T PL17710545 T PL 17710545T PL 3430031 T3 PL3430031 T3 PL 3430031T3
- Authority
- PL
- Poland
- Prior art keywords
- peptides
- cancer activity
- cancer
- activity
- Prior art date
Links
- 230000001093 anti-cancer Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/003—Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382114 | 2016-03-15 | ||
| EP17710545.9A EP3430031B1 (en) | 2016-03-15 | 2017-03-15 | Peptides with anti-cancer activity |
| PCT/EP2017/056074 WO2017157990A1 (en) | 2016-03-15 | 2017-03-15 | Peptides with anti-cancer activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3430031T3 true PL3430031T3 (pl) | 2022-04-19 |
Family
ID=55752233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17710545T PL3430031T3 (pl) | 2016-03-15 | 2017-03-15 | Peptydy o aktywności przeciwnowotworowej |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10639348B2 (pl) |
| EP (2) | EP3430031B1 (pl) |
| JP (1) | JP7098163B2 (pl) |
| CN (1) | CN109071622B (pl) |
| AU (2) | AU2017235382B2 (pl) |
| DK (1) | DK3430031T3 (pl) |
| ES (1) | ES2906782T3 (pl) |
| PL (1) | PL3430031T3 (pl) |
| PT (1) | PT3430031T (pl) |
| WO (1) | WO2017157990A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7361689B2 (ja) | 2017-07-25 | 2023-10-16 | イーデーペー・ディスカバリー・ファルマ，ソシエダッド・リミターダ | 抗がんペプチド |
| AU2018311129B2 (en) | 2017-08-01 | 2022-09-29 | Idp Discovery Pharma, S.L. | Anticancer peptides |
| CA3091948A1 (en) * | 2017-09-08 | 2019-03-14 | Idp Discovery Pharma, S.L. | New treatments of multiple myeloma |
| AR119529A1 (es) * | 2019-08-02 | 2021-12-22 | Idp Discovery Pharma S L | Péptidos reguladores de melanocitos |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| US7138370B2 (en) * | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
| SE0201863D0 (en) * | 2002-06-18 | 2002-06-18 | Cepep Ab | Cell penetrating peptides |
| FR2900341B1 (fr) * | 2006-04-27 | 2012-09-14 | Centre Nat Rech Scient | Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer |
| CN102884074A (zh) * | 2008-09-22 | 2013-01-16 | 爱勒让治疗公司 | 拟肽大环化合物 |
| IT1397901B1 (it) * | 2010-01-26 | 2013-02-04 | Consiglio Nazionale Ricerche | Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico. |
| SI2603600T1 (sl) * | 2010-08-13 | 2019-04-30 | Aileron Therapeutics, Inc. | Peptidomimetični makrocikli |
| HK1205454A1 (en) * | 2012-02-15 | 2015-12-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| WO2015057671A1 (en) * | 2013-10-14 | 2015-04-23 | The Broad Institute, Inc. | Artificial transcription factors comprising a sliding domain and uses thereof |
| ES2910550T3 (es) * | 2014-05-21 | 2022-05-12 | Icd Therapeutics Gmbh | Conjugados terapéuticos con dendrímeros sulfatados para selección de objetivos intracelulares |
-
2017
- 2017-03-15 PL PL17710545T patent/PL3430031T3/pl unknown
- 2017-03-15 DK DK17710545.9T patent/DK3430031T3/da active
- 2017-03-15 CN CN201780026767.3A patent/CN109071622B/zh active Active
- 2017-03-15 ES ES17710545T patent/ES2906782T3/es active Active
- 2017-03-15 AU AU2017235382A patent/AU2017235382B2/en active Active
- 2017-03-15 EP EP17710545.9A patent/EP3430031B1/en active Active
- 2017-03-15 WO PCT/EP2017/056074 patent/WO2017157990A1/en not_active Ceased
- 2017-03-15 PT PT177105459T patent/PT3430031T/pt unknown
- 2017-03-15 EP EP21203297.3A patent/EP4039698A1/en not_active Withdrawn
- 2017-03-15 US US16/084,927 patent/US10639348B2/en active Active
- 2017-03-15 JP JP2019500004A patent/JP7098163B2/ja active Active
-
2020
- 2020-03-12 US US16/817,226 patent/US11207379B2/en active Active
-
2021
- 2021-05-25 AU AU2021203397A patent/AU2021203397A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA3017424A1 (en) | 2017-09-21 |
| EP3430031A1 (en) | 2019-01-23 |
| WO2017157990A1 (en) | 2017-09-21 |
| EP4039698A1 (en) | 2022-08-10 |
| PT3430031T (pt) | 2022-01-24 |
| AU2021203397A1 (en) | 2021-06-24 |
| CN109071622B (zh) | 2023-01-13 |
| AU2017235382B2 (en) | 2021-02-25 |
| EP3430031B1 (en) | 2021-10-20 |
| CN109071622A (zh) | 2018-12-21 |
| US20210008159A1 (en) | 2021-01-14 |
| US10639348B2 (en) | 2020-05-05 |
| US11207379B2 (en) | 2021-12-28 |
| DK3430031T3 (da) | 2022-01-17 |
| AU2017235382A1 (en) | 2018-10-04 |
| JP2019516779A (ja) | 2019-06-20 |
| JP7098163B2 (ja) | 2022-07-11 |
| US20190083570A1 (en) | 2019-03-21 |
| ES2906782T3 (es) | 2022-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3250692T3 (pl) | Promotor i jego zastosowania | |
| GB201520559D0 (en) | Peptides | |
| GB201520575D0 (en) | Peptides | |
| GB201520539D0 (en) | Peptides | |
| PT3430031T (pt) | Péptidos com atividade anticancerígena | |
| GB201520536D0 (en) | Peptides | |
| GB201520543D0 (en) | Peptides | |
| GB201520546D0 (en) | Peptides | |
| GB201520545D0 (en) | Peptides | |
| GB201520563D0 (en) | Peptides | |
| GB201520562D0 (en) | Peptides | |
| GB201520544D0 (en) | Peptides | |
| GB201510804D0 (en) | Armrest assembly | |
| GB201520566D0 (en) | Peptides | |
| GB201520564D0 (en) | Peptides | |
| GB201520568D0 (en) | Peptides | |
| GB201520550D0 (en) | Peptides | |
| GB201520567D0 (en) | Peptides | |
| GB201520541D0 (en) | Peptides | |
| IL260479B (en) | Novel molecule with anti-cancer activity | |
| GB201520558D0 (en) | Peptides | |
| GB201520557D0 (en) | Peptides | |
| GB201520548D0 (en) | Peptides | |
| GB201520542D0 (en) | Peptides | |
| GB201520570D0 (en) | Peptides |